Insider Trading Activity For Evolent Health, Inc (NYSE:EVH)
Thomas Peterson III , COO of Evolent Health, Inc (NYSE:EVH) reportedly Sold 40,540 shares of the company’s stock at an average price of 26 for a total transaction amount of $1,054,040.00 SEC Form
Insider Trading History For Evolent Health, Inc (NYSE:EVH)
Analyst Ratings For Evolent Health, Inc (NYSE:EVH)
These are 12 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Evolent Health, Inc (NYSE:EVH) is Buy (Score: 3.08) with a consensus target price of $30.10 , a potential (15.33% upside)
Analyst Ratings History For Evolent Health, Inc (NYSE:EVH)
- On 8/5/2016 FBR & Co Boost Price Target of rating Outperform with a price target of $24.00 to $26.00
- On 9/30/2016 William Blair Reiterated Rating Outperform
- On 10/28/2016 J P Morgan Chase & Co Initiated Coverage of rating Overweight with a price target of $30.00
- On 1/13/2017 Wells Fargo & Company Upgraded rating Market Perform to Outperform
- On 2/3/2017 Canaccord Genuity Reiterated Rating Buy with a price target of $31.00
- On 3/1/2017 Cantor Fitzgerald Reiterated Rating Buy with a price target of $26.00
- On 3/8/2017 Goldman Sachs Group, Inc. (The) Upgraded rating Buy to Conviction-Buy with a price target of $30.00
Recent Trading Activity for Evolent Health, Inc (NYSE:EVH)
Shares of Evolent Health, Inc closed the previous trading session at 26.10 down -0.10 -0.38% with 363,746 shares trading hands.